Mental health systems in the US and UK have entered [...]

Milestone Pharmaceuticals has announced the commercial availability of CARDAMYST (etripamil) [...]

Grifols has received US Food and Drug Administration (FDA) approval [...]

Grifols has received US FDA approval for an expanded indication [...]

The US Food and Drug Administration (FDA) has approved KOMZIFTI [...]

Phase 3 data for GSK’s depemokimab appear to support the [...]

Er-Kim has signed an agreement with Sentynl Therapeutics to distribute [...]

Johnson & Johnson has dropped plans to develop its recently [...]

Insmed Incorporated, a global biopharmaceutical company focused on serious diseases, [...]

TISSIUM has received De Novo authorization from the US Food [...]